Paul P Chu, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2685 E High St, Springfield, OH 45505 Phone: 937-298-5333 |
Mark Tomsic, AA Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1343 N Fountain Blvd, Springfield, OH 45504 Phone: 937-390-5029 |
Kim Eugene Weber, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 100 W Main St, Springfield, OH 45502 Phone: 937-521-3900 |
Dan Thomas Hladky, AA Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1343 N Fountain Blvd, Springfield, OH 45501 Phone: 937-390-5029 |
Young R Park, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1343 N Fountain Blvd, Springfield, OH 45501 Phone: 937-390-5029 |
Thales N Pavlatos, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 100 W Main St, Springfield, OH 45502 Phone: 937-521-3900 |
Joseph Patrick Mader, AA Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1343 N Fountain Blvd, Springfield, OH 45501 Phone: 937-390-5029 |
Anshuman Swain, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2200 N Limestone St Ste 102, Springfield, OH 45503 Phone: 937-717-0954 Fax: 937-521-3467 |
George M. Boston, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1343 N Fountain Blvd, Springfield, OH 45504 Phone: 937-390-5000 |
Kamel Abraham, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1117 E Home Rd, Springfield, OH 45503 Phone: 937-298-5333 Fax: 937-298-5923 |
Mary Susan Andorfer, CRNA Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1343 N Fountain Blvd, Springfield, OH 45501 Phone: 937-390-5029 |
News Archive
Inari Medical, Inc. announced today that it has closed a $12.4 million Series B venture capital financing. The financing was led by members of the board of directors and returning investors Versant Ventures and US Venture Partners. The round also included participation by several medical device industry veterans.
The U.S. Food and Drug Administration has determined that Organon's gepirone ER New Drug Application is "not approvable."
MiMedx Group, Inc., the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic, and Dental sectors of healthcare, announced today that it has signed a definitive agreement to acquire Stability Inc., d/b/a Stability Biologics, a provider of human tissue products to surgeons, facilities and distributors serving the surgical, spine and orthopedics sectors of the healthcare industry.
"Global efforts to improve access to drinking water have been hampered by rapid urbanisation, with the proportion of people in urban areas with access actually declining, according to U.N. figures presented" at the World Water Week conference in Stockholm, Agence France-Presse reports.
› Verified 5 days ago